Pfizer to Cut Over 100 Jobs at Cork Plant as Pharma Sector Faces Headwinds
Pharmaceutical giant Pfizer has announced plans to cut more than 100 jobs at its Ringaskiddy plant in County Cork through redundancies later this year, in a blow to one of Ireland's most important industrial sectors.
The announcement, confirmed on Wednesday 22 April, affects the Ringaskiddy facility, which is one of Pfizer's key manufacturing sites in Ireland. The company cited ongoing restructuring and cost-reduction measures as the reason for the job losses, which are expected to be implemented through a voluntary redundancy process.
Impact on Cork
The Ringaskiddy plant is a significant employer in the Cork Harbour area, and the job losses will be felt keenly in the local community. The pharmaceutical sector is one of Ireland's most important industries, accounting for a significant proportion of the country's exports and employing tens of thousands of people across the country.
The cuts come at a challenging time for the global pharmaceutical industry, which is facing pressure from patent expirations, pricing reforms, and the need to invest heavily in new technologies including artificial intelligence and personalised medicine. Pfizer, like many of its peers, has been undertaking a significant restructuring programme in recent years following the end of the COVID-19 vaccine boom.
Broader Sector Context
The Pfizer announcement comes against a backdrop of mixed signals for Ireland's pharmaceutical and life sciences sector. While some companies are expanding — with significant investment in AI-driven drug discovery and manufacturing — others are rationalising their operations in response to changing market conditions.
Ireland's pharmaceutical sector has been a cornerstone of the country's economic success, with companies including Pfizer, Johnson & Johnson, AbbVie, and Eli Lilly operating major facilities across the country. The sector contributes billions of euros to Ireland's export figures and is a major source of high-skilled employment. For more, see the Irish Examiner's report.
What's Next?
Pfizer has indicated it will work with affected employees and their representatives to manage the redundancy process. The company has not indicated any plans to close the Ringaskiddy facility entirely, and the site is expected to continue operating with a reduced workforce. Trade unions representing workers at the plant are expected to engage with management in the coming weeks to negotiate terms for those affected.
